Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
2.300
+0.030 (1.32%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $463.17 million as of July 26, 2024. Its market cap has increased by 931.56% in one year.
Market Cap
463.17M
Enterprise Value
388.55M
1-Year Change
931.56%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $463.17M, a decrease of -32.92%. That is a compound annual growth rate of -9.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 430.10M | 29.98% |
| Dec 29, 2023 | 330.90M | 134.51% |
| Dec 30, 2022 | 141.10M | -68.52% |
| Dec 31, 2021 | 448.20M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.16% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Heron Therapeutics | 480.48M |
| MaxCyte | 475.15M |
| Aura Biosciences | 471.65M |
| Nano-X Imaging | 468.59M |
| GRAIL, LLC | 464.18M |
| Altimmune | 456.96M |
| Health Catalyst | 454.27M |
| Editas Medicine | 450.25M |